Source comparison
BPC-157 for ACL Tear Recovery Research: Comparison Table
The table below compares BPC-157 research findings across different ligament injury models and administration protocols. | Study Model | Administration Route | Dosage | Healing Timeline Improvement | Tensile Strength at 28 Days | Key Limitation ||—|—|—|—|—|| R
This comparison does not assign a generated winner or score.
- The table below compares BPC-157 research findings across different ligament injury models and administration protocols.
- | Study Model | Administration Route | Dosage | Healing Timeline Improvement | Tensile Strength at 28 Days | Key Limitation ||—|—|—|—|—|| Rat Achilles Tendon (2019) | Subcutaneous peri-injury | 10 μg/kg daily × 14 days | 40% faster collagen deposition | +73% vs control | Different tissue vascularity than ACL || Rat MCL Transection (2018) | Intraperitoneal systemic | 10 μg/kg daily × 28 days | 44% faster return to baseline strength | 73% of pre-injury load | Rodent metabolism differs from human || Human ACL Case Reports (2021) | Subcutaneous self-administered | 250–500 μg daily × 60 days | Subjective pain reduction 3–4 weeks | Not measured | No control group or objective metrics || Rat Patellar Tendon (2020) | Intramuscular distant site | 5 μg/kg daily × 21 days | 58% higher Type I collagen content | +41% vs control | Tendon healing differs from intra-articular ligament |